Japan Pharma Group Calls for Careful Approach on PMP Deduction for Comparator Drugs

June 19, 2018
The government should hold careful discussions on a plan to deduct the price maintenance premium (PMP) from PMP-granted comparator drugs if their prices are referred to in the pricing of newly approved drugs that would not qualify for the PMP...read more